Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44,542,200
-
Total 13F shares
-
6,384,233
-
Share change
-
+6,106,868
-
Total reported value
-
$82,677,000
-
Price per share
-
$12.95
-
Number of holders
-
22
-
Value change
-
+$79,084,018
-
Number of buys
-
19
Institutional Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q4 2019
As of 31 Dec 2019,
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,384,233 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, Essex Woodlands Management, Inc., FEDERATED HERMES, INC., Woodline Partners LP, Alyeska Investment Group, L.P., Opaleye Management Inc., Schonfeld Strategic Advisors LLC, MILLENNIUM MANAGEMENT LLC, and Pentwater Capital Management LP.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.